日本新技术事业团再生机能研究小组目前宣布已开发出治疗糖尿病的新技术。这种新技术是制造胰岛素原的遗传基因组人工皮肤,然后,通过移植这种基因重组过的人工皮肤治疗糖尿病。研究人员先向一种叫胶原的蛋白质中输入制造皮肤的纤维芽细胞,制作出称之为真皮的皮肤基础部分。然后 Japan’s new technology group regeneration function research group currently announced that it has developed a new technology for the treatment of diabetes. The new technology is to make proinsulin genomic artificial skin, which is then used to treat diabetes by transplanting the genetically modified artificial skin. Researchers first imported fibroblasts that make skin into a protein called collagen to make a dermal base called dermis. then